Mesothelioma Lawyers Near Me

Chemotherapy

2 articles on this topic

Medical

Peritoneal Mesothelioma Treatment in 2026: 5-Year Survival Rates Reach 59% With CRS-HIPEC

David Foster

David Foster

March 5, 2026

2026 peritoneal mesothelioma treatment advances: CRS-HIPEC surgery pushes 5-year survival to 59%, with median survival 4-8 years. Emerging immunotherapy options included.

13 min read 6 FAQs
Read
Medical

CRS-HIPEC for Peritoneal Mesothelioma: Understanding the 69% Five-Year Survival Rate

David Foster

David Foster

February 26, 2026

CRS-HIPEC (cytoreductive surgery + hyperthermic chemotherapy) achieves 69% five-year survival for eligible peritoneal mesothelioma patients. Learn candidacy, outcomes, and leading treatment centers.

14 min read 8 FAQs
Read

Related Topics

Peritoneal Mesothelioma CRS-HIPEC Treatment Mesothelioma Surgery Clinical Trials Survival Rates Treatment Centers Medical Innovation CRS-HIPEC Surgery Mesothelioma Treatment Cancer Treatment 2026 Updates
Back to All Posts

Have Questions About Your Case?

Our experienced mesothelioma attorneys are here to help you understand your options.

Call 855-699-5441 Free Case Assessment